Identification and validation of microRNA (miRNA) target genes is essential for gaining a better understanding of the many different functions miRNAs have in healthy and diseased cells. From a practical standpoint, validated target genes are also useful for monitoring pharmacological activity of developmental therapeutics that modulate miRNAs, such as anti-miRNA oligonucleotides (anti-miR). Here, we describe a method that uses changes in Argonaute 2-RNA immunoprecipitation in response to competition by anti-miR, titrated ex vivo, as physical evidence for target validation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-4939-6563-2_6 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!